4.3 Article

Normal expression levels of cathepsins, protease inhibitors, and Sp1 in conjunctival tissues from patients with keratoconus

期刊

CURRENT EYE RESEARCH
卷 21, 期 5, 页码 886-890

出版社

TAYLOR & FRANCIS INC
DOI: 10.1076/ceyr.21.5.886.5538

关键词

cathepsins; conjunctiva; keratoconus; protease inhibitors; transcription factor

资金

  1. NEI NIH HHS [EY 03890, EY 01792, EY 05628] Funding Source: Medline
  2. NATIONAL EYE INSTITUTE [P30EY001792, R01EY003890] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Purpose. In keratoconus corneas, it has been shown that levels of degradative enzymes and transcription factor Sp1 are elevated and those of inhibitors are reduced, especially in the epithelial layer. This study is to determine whether the biochemical abnormalities identified in corneas also exist in conjunctival tissues. Methods. Conjunctival tissues were collected from normal subjects and from patients with keratoconus, senile cataract, and other corneal diseases. Immunohistochemical staining for cathepsins B and G, alpha1-proteinase inhibitor, alpha2-macroglobulin and Sp1 was performed. Results. The epithelium of all conjunctival specimens showed immunoreactivity toward the antibodies. The staining for cathepsins B and G, and the inhibitors was mostly cytoplasmic, while that for Sp1 was nuclear. The staining intensity in keratoconus specimens was all within normal range. Conclusions. These results suggest that the abnormalities in cathepsins B and G, protease inhibitors and Sp1 identified in keratoconus corneas are not manifested in the conjunctiva. Keratoconus appears to be a disease localized to the cornea.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据